International Union of Pharmacology. LXIV. Estrogen Receptors

Estrogen receptors (ERs[1][1]) are ligand-activated transcription factors that belong to the nuclear hormone receptor superfamily. In the late 1950s, the existence of a receptor molecule that could bind 17β-estradiol was demonstrated by Jensen and Jacobsen ([Jensen and Jordan, 2003][2]). The first

[1]  W. Gradishar,et al.  Selective estrogen receptor modulators and prevention of invasive breast cancer. , 2006, JAMA.

[2]  Norman Wolmark,et al.  Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. , 2006, JAMA.

[3]  K. Korach,et al.  17beta-estradiol induces apoptosis in the developing rodent prostate independently of ERalpha or ERbeta. , 2006, Endocrinology.

[4]  K. Korach,et al.  17β-Estradiol Induces Apoptosis in the Developing Rodent Prostate Independently of ERα or ERβ , 2006 .

[5]  V. Jordan,et al.  Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. , 2005, Mutation research.

[6]  D. McDonnell,et al.  Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting. , 2005, Molecular interventions.

[7]  Byung-Mu Lee,et al.  Assessment of Estrogenic and Androgenic Activities of Tetramethrin in Vitro and in Vivo Assays , 2005, Journal of toxicology and environmental health. Part A.

[8]  R. Millikan,et al.  The estrogen receptor-α A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study , 2005, Breast Cancer Research.

[9]  Miguel A Hernán,et al.  Recent use of oral contraceptives and the risk of multiple sclerosis. , 2005, Archives of neurology.

[10]  F. Naftolin,et al.  Is the Estrogen Controversy Over? Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence , 2005, Annals of the New York Academy of Sciences.

[11]  W. Boon,et al.  Estrogen, a fundamental player in energy homeostasis , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[12]  C. Burke.  Endometrial cancer and tamoxifen. , 2005, Clinical journal of oncology nursing.

[13]  R. Bhat,et al.  Identification of pathway-selective estrogen receptor ligands that inhibit NF-kappaB transcriptional activity. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Lindgren,et al.  Effects of anti-estrogens on bone in castrated and intact female rats , 1987, Breast Cancer Research and Treatment.

[15]  Yukun Cui,et al.  Phosphorylation of Estrogen Receptor α Blocks Its Acetylation and Regulates Estrogen Sensitivity , 2004, Cancer Research.

[16]  K. Korach,et al.  Estrogen receptor-alpha mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract. , 2004, Toxicology.

[17]  Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  J. Gustafsson,et al.  Estrogen Receptor-Beta Regulates Epithelial Cell Differentiation in the Mouse Ventral Prostate , 2004, Hormone Research in Paediatrics.

[19]  J. Gustafsson,et al.  Estrogen receptor β regulates epithelial cellular differentiation in the mouse ventral prostate , 2004 .

[20]  E. Tokunaga,et al.  No Hypersensitive Estrogen Receptor-α Mutation (K303R) in Japanese Breast Carcinomas , 2004, Breast Cancer Research and Treatment.

[21]  G. B. Lopes,et al.  Effects of estrogen plus progestin on health-related quality of life. , 2004, The New England journal of medicine.

[22]  J. Kemper,et al.  Differential regulation of the human progesterone receptor gene through an estrogen response element half site and Sp1 sites , 2004, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  C. Bailey,et al.  Role of ovarian hormones in the long-term control of glucose homeostasis , 1980, Diabetologia.

[24]  E. Tokunaga,et al.  No hypersensitive estrogen receptor-alpha mutation (K303R) in Japanese breast carcinomas. , 2004, Breast cancer research and treatment.

[25]  R. Brinton.  Impact of Estrogen Therapy on Alzheimer’s Disease , 2004, CNS drugs.

[26]  Wade V Welshons,et al.  Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. , 2004, Cancer research.

[27]  M Nilsson,et al.  Association of estrogen receptor β gene polymorphisms with bulimic disease in women , 2004, Molecular Psychiatry.

[28]  K. Korach,et al.  Estrogen receptor knockout mice as a model for endocrine research. , 2004, ILAR journal.

[29]  Dennis B. Lubahn,et al.  Estrogen Receptor α Mediates Estrogen’s Immune Protection in Autoimmune Disease , 2003, The Journal of Immunology.

[30]  N. Sicotte,et al.  Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol 1 , 2003, The Journal of Immunology.

[31]  E. Lam,et al.  Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. , 2003, Oncogene.

[32]  D. Labuda,et al.  Human estrogen receptor beta 548 is not a common variant in three distinct populations. , 2003, Endocrinology.

[33]  J. Gustafsson,et al.  Update on estrogen signaling , 2003, FEBS letters.

[34]  B. Bhavnani.  Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer’s , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[35]  J. Lovejoy.  The menopause and obesity. , 2003, Primary care.

[36]  V. Jordan,et al.  The estrogen receptor: a model for molecular medicine. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  S. Malhotra,et al.  Effect of hormone replacement therapy on cardiovascular disease: current opinion , 2003, Expert opinion on pharmacotherapy.

[38]  D. Lubahn,et al.  Estrogen receptor alpha mediates estrogen's immune protection in autoimmune disease. , 2003, Journal of immunology.

[39]  E. Barrett-Connor,et al.  Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial. , 2002, The American journal of cardiology.

[40]  G. Patrinos,et al.  DNA hypermethylation: when tumour suppressor genes go silent , 2002, Human Genetics.

[41]  J. Gustafsson,et al.  pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element. , 2002, Molecular pharmacology.

[42]  P. Chambon,et al.  Estrogen Receptor-&agr; Mediates the Protective Effects of Estrogen Against Vascular Injury , 2002, Circulation research.

[43]  David A. Agard,et al.  Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism , 2002, Nature Structural Biology.

[44]  Myles Brown,et al.  Molecular Determinants for the Tissue Specificity of SERMs , 2002, Science.

[45]  E. Bleecker,et al.  Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. , 2002, The New England journal of medicine.

[46]  J. Gustafsson,et al.  Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor β , 2002, Science.

[47]  R. Baron,et al.  Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males. , 2002, Bone.

[48]  Martin Koš,et al.  0888-8809/01/$03.00/0 Molecular Endocrinology 15(12):2057–2063 Printed in U.S.A. Copyright © 2001 by The Endocrine Society Minireview: Genomic Organization of the Human ER � Gene Promoter Region , 2022 .

[49]  V. Speirs,et al.  Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[50]  B. Katzenellenbogen,et al.  Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. , 2001, Journal of medicinal chemistry.

[51]  K. Korach,et al.  Estrogen Receptor-α Knockout Mice Exhibit Resistance to the Developmental Effects of Neonatal Diethylstilbestrol Exposure on the Female Reproductive Tract , 2001 .

[52]  K. Belguise,et al.  Characterization of the Physical Interaction between Estrogen Receptor α and JUN Proteins* , 2001, The Journal of Biological Chemistry.

[53]  G. Lazennec.  ER Inhibits Proliferation and Invasion of Breast Cancer Cells , 2001 .

[54]  A. Lucas,et al.  ERβ Inhibits Proliferation and Invasion of Breast Cancer Cells. , 2001, Endocrinology.

[55]  D. Lubahn,et al.  Estrogen receptor‐ and aromatase‐deficient mice provide insight into the roles of estrogen within the ovary and uterus * , 2001, Molecular reproduction and development.

[56]  S. Safe,et al.  Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[57]  B. Katzenellenbogen,et al.  Direct Acetylation of the Estrogen Receptor α Hinge Region by p300 Regulates Transactivation and Hormone Sensitivity* , 2001, The Journal of Biological Chemistry.

[58]  M. Helder,et al.  Is GnRH self-priming an obligatory feature of the reproductive cycle? , 2001, Human reproduction.

[59]  S. Safe.  Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor-Sp1 interactions. , 2001, Vitamins and hormones.

[60]  F. Gannon,et al.  Minireview: genomic organization of the human ERalpha gene promoter region. , 2001, Molecular endocrinology.

[61]  K. Belguise,et al.  Characterization of the physical interaction between estrogen receptor alpha and JUN proteins. , 2001, The Journal of biological chemistry.

[62]  K. Korach,et al.  Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. , 2001, Developmental biology.

[63]  A. Lucas,et al.  ER beta inhibits proliferation and invasion of breast cancer cells. , 2001, Endocrinology.

[64]  Y. Miyoshi,et al.  Quantitative analysis of estrogen receptor‐β mRNA and its variants in human breast cancers , 2000, International journal of cancer.

[65]  B. Katzenellenbogen,et al.  Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. , 2000, Journal of medicinal chemistry.

[66]  Satoshi Inoue,et al.  Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure , 2000, Journal of Human Genetics.

[67]  F. Gannon,et al.  Identification of a new isoform of the human estrogen receptor‐alpha (hER‐α) that is encoded by distinct transcripts and that is able to repress hER‐α activation function 1 , 2000 .

[68]  J. Gustafsson,et al.  Functional Differences between the Amino-Terminal Domains of Estrogen Receptors α and β , 2000 .

[69]  S. Hilsenbeck,et al.  A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions. , 2000, Cancer research.

[70]  C. Klinge,et al.  Estrogen receptor interaction with co-activators and co-repressors☆ , 2000, Steroids.

[71]  E. Mazzon,et al.  17β-Estradiol Antiinflammatory Activity in Carrageenan-Induced Pleurisy. , 2000, Endocrinology.

[72]  Y. Ouchi,et al.  Association of Estrogen Receptor β Gene Polymorphism with Bone Mineral Density , 2000 .

[73]  F. Gannon,et al.  Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. , 2000, The EMBO journal.

[74]  R. Dahiya,et al.  Cloning and characterization of human estrogen receptor beta promoter. , 2000, Biochemical and biophysical research communications.

[75]  Y. Ouchi,et al.  Association of estrogen receptor beta (ESR2) gene polymorphism with blood pressure. , 2000, Journal of human genetics.

[76]  Y. Ouchi,et al.  Association of estrogen receptor beta gene polymorphism with bone mineral density. , 2000, Biochemical and biophysical research communications.

[77]  E. Mazzon,et al.  17beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. , 2000, Endocrinology.

[78]  J. Gustafsson,et al.  Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. , 2000, Molecular pharmacology.

[79]  R. Karas,et al.  The protective effects of estrogen on the cardiovascular system. , 2002, The New England journal of medicine.

[80]  P. Mecocci,et al.  Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. , 1999, Biochemical and biophysical research communications.

[81]  L. Moore,et al.  Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. , 1999, Cancer research.

[82]  B. Ponder,et al.  A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1 , 2000 .

[83]  K E Carlson,et al.  Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes. , 1999, Journal of medicinal chemistry.

[84]  B. Katzenellenbogen,et al.  Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. , 1999, Endocrinology.

[85]  J. Hebebrand,et al.  Systematic mutation screening of the estrogen receptor beta gene in probands of different weight extremes: identification of several genetic variants. , 1998, The Journal of clinical endocrinology and metabolism.

[86]  Helmut Dotzlaw,et al.  Estrogen receptor beta: mine is longer than yours? , 1998, The Journal of clinical endocrinology and metabolism.

[87]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[88]  Y. Ouchi,et al.  Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human , 1998 .

[89]  J. Gustafsson,et al.  Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.

[90]  J. Lehmann,et al.  Cloning and Characterization of Human Estrogen Receptor β Isoforms , 1998 .

[91]  Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm. , 1998, Molecular endocrinology.

[92]  S. Kato,et al.  A novel isoform of rat estrogen receptor beta with 18 amino acid insertion in the ligand binding domain as a putative dominant negative regular of estrogen action. , 1998, Biochemical and biophysical research communications.

[93]  Y. Ouchi,et al.  The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. , 1998, Biochemical and biophysical research communications.

[94]  J. Corton,et al.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. , 1998, Endocrinology.

[95]  Y. Ouchi,et al.  Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. , 1998, Nucleic acids research.

[96]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[97]  S. Chu,et al.  Identification of a splice variant of the rat estrogen receptor β gene , 1997, Molecular and Cellular Endocrinology.

[98]  S. Safe,et al.  Identification of a functional imperfect estrogen-responsive element in the 5'-promoter region of the human cathepsin D gene. , 1997, Biochemistry.

[99]  N. Copeland,et al.  Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor beta. , 1997, Molecular endocrinology.

[100]  J. Gustafsson,et al.  Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. , 1997, Endocrinology.

[101]  S. Chu,et al.  Identification of a splice variant of the rat estrogen receptor beta gene. , 1997, Molecular and Cellular Endocrinology.

[102]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[103]  E. May,et al.  Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues , 1995, Molecular and Cellular Endocrinology.

[104]  K. Korach,et al.  Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. , 1994, The New England journal of medicine.

[105]  M. Tzukerman,et al.  Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. , 1994, Molecular endocrinology.

[106]  G. Aguiari,et al.  Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene. , 1992, Human molecular genetics.

[107]  Y. Edwards,et al.  Two TaqI polymorphisms at the human PGM1 locus. , 1992, Human molecular genetics.

[108]  J. Ham,et al.  Structural organization and expression of the mouse estrogen receptor. , 1987, Molecular endocrinology.

[109]  S. Koike,et al.  Molecular cloning and characterization of rat estrogen receptor cDNA. , 1987, Nucleic acids research.

[110]  P. Argos,et al.  Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A , 1986, Nature.

[111]  J. Shine,et al.  Sequence and expression of human estrogen receptor complementary DNA. , 1986, Science.

[112]  C. Bailey,et al.  Role of ovarian hormones in the long-term control of glucose homeostasis. Effects of insulin secretion. , 1980, Diabetologia.